Page last updated: 2024-08-22

angiotensin ii and Hepato-Pulmonary Syndrome

angiotensin ii has been researched along with Hepato-Pulmonary Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ali, FEM; Bakr, AG; El-Bahrawy, AH; Taha, HH	1

Other Studies

1 other study(ies) available for angiotensin ii and Hepato-Pulmonary Syndrome

Article	Year
Diosmin enhances the anti-angiogenic activity of sildenafil and pentoxifylline against hepatopulmonary syndrome via regulation of TNF-α/VEGF, IGF-1/PI3K/AKT, and FGF-1/ANG-2 signaling pathways. European journal of pharmacology, 2020, Apr-15, Volume: 873 Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Diosmin; Drug Synergism; Fibroblast Growth Factor 1; Hepatopulmonary Syndrome; Insulin-Like Growth Factor I; Male; Pentoxifylline; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Sildenafil Citrate; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2020

Article

Year

Diosmin enhances the anti-angiogenic activity of sildenafil and pentoxifylline against hepatopulmonary syndrome via regulation of TNF-α/VEGF, IGF-1/PI3K/AKT, and FGF-1/ANG-2 signaling pathways.

European journal of pharmacology, 2020, Apr-15, Volume: 873

Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Diosmin; Drug Synergism; Fibroblast Growth Factor 1; Hepatopulmonary Syndrome; Insulin-Like Growth Factor I; Male; Pentoxifylline; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Sildenafil Citrate; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2020